1. Home
  2. AMCR vs NBIX Comparison

AMCR vs NBIX Comparison

Compare AMCR & NBIX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Amcor plc

AMCR

Amcor plc

HOLD

Current Price

$8.31

Market Cap

19.0B

ML Signal

HOLD

Logo Neurocrine Biosciences Inc.

NBIX

Neurocrine Biosciences Inc.

HOLD

Current Price

$155.51

Market Cap

14.4B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
AMCR
NBIX
Founded
1926
1992
Country
Switzerland
United States
Employees
N/A
N/A
Industry
Miscellaneous manufacturing industries
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
19.0B
14.4B
IPO Year
N/A
1996

Fundamental Metrics

Financial Performance
Metric
AMCR
NBIX
Price
$8.31
$155.51
Analyst Decision
Buy
Strong Buy
Analyst Count
7
19
Target Price
$10.40
$173.79
AVG Volume (30 Days)
22.7M
969.9K
Earning Date
11-05-2025
10-28-2025
Dividend Yield
6.26%
N/A
EPS Growth
N/A
12.44
EPS
0.32
4.19
Revenue
$17,401,000,000.00
$2,682,700,000.00
Revenue This Year
$57.16
$23.76
Revenue Next Year
$1.28
$18.01
P/E Ratio
$25.88
$37.10
Revenue Growth
28.42
19.61
52 Week Low
$7.67
$84.23
52 Week High
$10.47
$157.67

Technical Indicators

Market Signals
Indicator
AMCR
NBIX
Relative Strength Index (RSI) 46.46 64.81
Support Level $8.31 $150.26
Resistance Level $8.59 $154.35
Average True Range (ATR) 0.14 4.16
MACD -0.03 1.07
Stochastic Oscillator 11.39 93.25

Price Performance

Historical Comparison
AMCR
NBIX

About AMCR Amcor plc

Amcor is a global producer of plastic packaging primarily for the fast-moving consumer goods industry. About 90% of earnings are exposed to the flexible packaging business. This is soft disposable plastic for a variety of food, drink, healthcare, and hygiene products. The remainder of earnings are from the Latin and North American rigids business, which is primarily beverage bottling for the soft drink industry. Operating in more than 35 countries, Amcor has market share in its established regions of North America, Latin America, Europe, and Asia-Pacific. About half of group sales are derived from North America and the remainder is split equally between Western Europe and emerging markets. Australia and New Zealand sales make up less than 5% of group sales.

About NBIX Neurocrine Biosciences Inc.

Neurocrine Biosciences Inc engages in the discovery, development, and commercialization of drugs for the treatment of neurological and endocrine-related diseases and disorders in the United States. The company's products include INGREZZA for tardive dyskinesia and chorea associated with Huntington's disease; ALKINDI for adrenal insufficiency; Efmody capsules for classic congenital adrenal hyperplasia; Orilissa tablets for endometriosis; and Oriahnn capsules to treat uterine fibroids.

Share on Social Networks: